What Is Charming Medical Limited (MCTA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Charming Medical Limited's intrinsic value is estimated at $13.27, suggesting the stock is overvalued at its current price of $29.36. With 8 out of 10 models flagging downside (-54.8% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: Sentiment SOTP targets $34.76 (+18.4%), versus RCMH-DCF at $0.66 (-97.8%). This +116.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About MCTA?
10 of 13 models are currently active for MCTA. Of these, 1 model suggests upside while 9 models suggest overvaluation. The Bayesian DCF estimates MCTA's intrinsic value at $7.78, implying -73.5% downside from the current price. See which stocks rank higher →
How Does MCTA Rank in Services-Misc Health & Allied Services, NEC?
Among 11 Services-Misc Health & Allied Services, NEC stocks, MCTA ranks #10 by Quality of Company score. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.
Charming Medical Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is MCTA a Value Trap?
The Value Trap algorithm is not active for MCTA. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Charming Medical Limited. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Charming Medical Limited's fundamental quality profile registers 2.0/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +116.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MCTA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MCTA's 10 active models, average confidence is 3%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad